Correlation Between Unicycive Therapeutics and Viracta Therapeutics
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Viracta Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Viracta Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and Viracta Therapeutics, you can compare the effects of market volatilities on Unicycive Therapeutics and Viracta Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Viracta Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Viracta Therapeutics.
Diversification Opportunities for Unicycive Therapeutics and Viracta Therapeutics
-0.76 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Unicycive and Viracta is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Viracta Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viracta Therapeutics and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Viracta Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viracta Therapeutics has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Viracta Therapeutics go up and down completely randomly.
Pair Corralation between Unicycive Therapeutics and Viracta Therapeutics
Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 1.58 times more return on investment than Viracta Therapeutics. However, Unicycive Therapeutics is 1.58 times more volatile than Viracta Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Viracta Therapeutics is currently generating about -0.05 per unit of risk. If you would invest 71.00 in Unicycive Therapeutics on September 5, 2024 and sell it today you would earn a total of 0.00 from holding Unicycive Therapeutics or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Unicycive Therapeutics vs. Viracta Therapeutics
Performance |
| Timeline |
| Unicycive Therapeutics |
| Viracta Therapeutics |
Unicycive Therapeutics and Viracta Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Unicycive Therapeutics and Viracta Therapeutics
The main advantage of trading using opposite Unicycive Therapeutics and Viracta Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Viracta Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viracta Therapeutics will offset losses from the drop in Viracta Therapeutics' long position.| Unicycive Therapeutics vs. Transcode Therapeutics | Unicycive Therapeutics vs. Cardio Diagnostics Holdings |
| Viracta Therapeutics vs. Candel Therapeutics | Viracta Therapeutics vs. Cingulate Warrants | Viracta Therapeutics vs. Unicycive Therapeutics | Viracta Therapeutics vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |